Ligand validation:1RA9

NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE

NAP is a Ligand Of Interest in 1RA9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1RA9_NAP_A_164	93%	12%	0.034	0.993	2.66	1.47	9	6	2	0	65%	0.6458
4PSY_NAP_A_202	100%	56%	0.035	0.994	0.9	0.82	2	-	3	0	100%	1
4RGC_NAP_A_202	100%	54%	0.04	0.995	0.89	0.88	2	1	1	0	100%	1
7FQ8_NAP_A_202	100%	41%	0.037	0.988	1.04	1.26	4	6	1	0	100%	1
7FQ9_NAP_A_202	100%	49%	0.04	0.988	0.94	1.03	2	4	1	0	100%	1
8UW0_NAP_A_202	100%	24%	0.046	0.993	1.91	1.23	10	6	1	0	100%	1
2EXX_NAP_A_3698	100%	10%	0.025	0.996	1.63	2.7	7	18	9	0	100%	1
2DBQ_NAP_A_401	100%	24%	0.017	0.998	1.42	1.71	7	16	0	0	100%	1
2X9G_NAP_B_1269	100%	46%	0.031	0.997	0.96	1.14	1	5	0	0	100%	1
2J8T_NAP_A_1316	100%	49%	0.033	0.996	0.97	1.01	3	2	1	0	100%	1
3LQL_NAP_A_500	100%	43%	0.035	0.996	1.13	1.07	3	4	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.